In the cold state, we found that the tumor CD99 pathway plays a strong role, and it has been shown to be a potential new target for the CAR-T therapy of T-cell acute lymphoblastic leukemia [47]. Here, CD99 is linked to T-cell acute lymphoblastic leukemia.